Anesthesia for Retinopathy of Prematurity
Retinopathy
About this trial
This is an interventional treatment trial for Retinopathy focused on measuring Prematurity, Retinopathy, propofol, ketamine, sedation
Eligibility Criteria
Inclusion Criteria:
- infants aged 32-40 weeks who were scheduled to undergo laser surgery for treatment of ROP
Exclusion Criteria:
- The exclusion criteria were patients requiring inotropic support,
- the need for mechanical ventilation or intubation in the 3 days prior to the operation,
- known allergy or hypersensitivity reaction to ketamine and propofol,
- age ˃40 weeks.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
sedation
general anesthesia
The sedation group (Group S, n=30), received 1 mg/kg ketamine and 1 mg/kg propofol as a bolus for induction. The patients then received an infusion of 100-150 mcg/kg/min propofol and 0.25mg/kg/h of ketamine for maintenance.
In the general anesthesia group (Group G, n=30), anesthesia was induced using 8% sevoflurane by inhalation with 50% nitrous oxide in oxygen; endotracheal intubation was facilitated without use of a neuromuscular blocker agent. Anesthesia was maintained with sevoflurane (2%) and 50% nitrous oxide in oxygen.